Pershing to Allergan: Take the deal

Major shareholder and activist investor Pershing Capital Management urges Allergan to take Valeant Pharmaceuticals up on its $47 billion offer.

Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kSwjes